Company: CSCIF
Filing Date: 2025-04-09
Form Type: 20-F
Source: 0001641172-25-003456
Chunk: 122

Company: COSCIENS Biopharma Inc.
Filing Date: 2025-04-09
Form: 20-F
Item: Item 6
Chunk 122
---
───────

Not applicable.

  Dilution  
 ────────────

Not applicable.

  Expenses of the issue  
 ─────────────────────────

Not applicable.

  Item 10.      Additional Information  
 ────────────────────────────────────────

  Share capital  
 ─────────────────

Not required.

  Memorandum and articles of association  
 ──────────────────────────────────────────

We are governed by our restated articles of incorporation
(the “ Restated Articles of Incorporation”) under the CBCA and by articles of amendment dated October 2, 2012, November
17, 2015, May 9, 2019, July 18, 2022, April 30, 2024 and August 6, 2024 (together with the Restated Articles of Incorporation, the “Articles”)
and by our bylaws, as amended and restated on March 21, 2013 (the “ bylaws”). Our Articles are on file with Corporations
Canada under Corporation Number 264271-9. The Articles do not include a stated purpose and do not place any restrictions on the business
that we may carry on.

Inspection Rights of Shareholders

Under the CBCA, shareholders are entitled to be provided
with a copy of the list of our registered shareholders. In order to obtain the shareholder list, a shareholder must provide to us an
affidavit including, among other things, a statement that the list will only be used for the purposes permitted by the CBCA. These permitted
purposes include an effort to influence the voting of our shareholders, an offer to acquire our securities and any other matter relating
to our affairs. We are entitled to charge a reasonable fee for the provision of the shareholder list and must deliver that list no more
than ten days after receipt of the affidavit described above.

  83  

Under the CBCA, shareholders have the right to inspect
certain corporate records, including our Articles and bylaws and minutes of meetings and resolutions of the shareholders. Shareholders
have no statutory right to inspect minutes of meetings and resolutions of our directors. Our shareholders have the right to certain financial
information respecting us. In addition to the annual and quarterly financial statements required to be filed under applicable securities
laws, we are required by the CBCA to place before every annual meeting of shareholders our audited comparative annual financial statements.
In addition, shareholders have the right to examine the financial statements of each of our subsidiaries and